At Bayer Pharmaceuticals, we made a decision that would sound reckless in many large companies: we stopped assigning sales targets to regions or countries.
We did not eliminate accountability. We shifted it – from an annual number handed down from headquarters to employees deciding where resources will produce the greatest return for patients and the business.
